SOPHiA GENETICS (SOPH) Change in Receivables (2020 - 2026)

SOPHiA GENETICS has disclosed Change in Receivables across 7 years of filings, most recently posting $120000.0 for Q2 2026.

• In Q2 2026, Change in Receivables fell 92.78% year-over-year to $120000.0; the TTM figure through Jun 2026 stood at -$4.7 million (down 403.87% YoY), while the FY2025 annual figure was -$6.6 million, down 212.07% from the prior year.
• Change in Receivables came in at $120000.0 for Q2 2026 at SOPHiA GENETICS, down from $469000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $2.3 million in Q2 2023 to a low of -$6.6 million in Q4 2025.
• Average Change in Receivables over 5 years is -$293888.9, with a median of $294500.0 recorded in 2026.
• The largest YoY upside for Change in Receivables was 395.94% in 2023 against a maximum downside of 158350.0% in 2023.
• Over 5 years, Change in Receivables stood at $2.0 million in 2022, then slumped by 278.77% to -$3.6 million in 2023, then jumped by 157.43% to $2.1 million in 2024, then plunged by 419.1% to -$6.6 million in 2025, then jumped by 101.81% to $120000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $120000.0 in Q2 2026, $469000.0 in Q1 2026, and -$6.6 million in Q4 2025.